BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34256780)

  • 1. Gastric mucin phenotype indicates aggressive biological behaviour in early differentiated gastric adenocarcinomas following endoscopic treatment.
    Song K; Yang Q; Yan Y; Yu X; Xu K; Xu J
    Diagn Pathol; 2021 Jul; 16(1):62. PubMed ID: 34256780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach.
    Shiratsu K; Higuchi K; Nakayama J
    Cancer Sci; 2014 Jan; 105(1):126-33. PubMed ID: 24138592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
    Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
    Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
    Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
    Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cell cycle-related proteins in gastric intramucosal differentiated-type cancers based on mucin phenotypes: a novel hypothesis of early gastric carcinogenesis based on mucin phenotype.
    Sugai T; Tsukahara M; Endoh M; Shioi Y; Takebe N; Mue Y; Matsushita H; Toyota M; Suzuki K
    BMC Gastroenterol; 2010 Jun; 10():55. PubMed ID: 20525401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic and clinicopathological features of intramucosal, histologically mixed-type, low-grade, well-differentiated gastric tubular adenocarcinoma with the potential for late-onset lymph node metastasis.
    Saitoh T; Takamura A; Watanabe G
    BMC Gastroenterol; 2018 Dec; 18(1):189. PubMed ID: 30587141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
    Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
    Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical and pathological features between early-stage gastric-type and intestinal-type differentiated adenocarcinoma: a retrospective study.
    Li B; Chen T; Liang D; Zhang Y; Ding X; Lv Y
    BMC Gastroenterol; 2023 Mar; 23(1):92. PubMed ID: 36977979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma.
    Nakamura T; Yao T; Kabashima A; Nishiyama K; Maehara Y; Tsuneyoshi M
    Histopathology; 2005 Oct; 47(4):357-67. PubMed ID: 16178890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
    Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unclassified mucin phenotype of gastric adenocarcinoma exhibits the highest invasiveness.
    Han HS; Lee SY; Lee KY; Hong SN; Kim JH; Sung IK; Park HS; Jin CJ; Min YI
    J Gastroenterol Hepatol; 2009 Apr; 24(4):658-66. PubMed ID: 19175827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations.
    Yamazaki K; Tajima Y; Makino R; Nishino N; Aoki S; Kato M; Sakamoto M; Morohara K; Kaetsu T; Kusano M
    World J Gastroenterol; 2006 Jun; 12(24):3803-9. PubMed ID: 16804962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.
    Morohara K; Tajima Y; Nakao K; Nishino N; Aoki S; Kato M; Sakamoto M; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Tachikawa T; Kusano M
    J Cancer Res Clin Oncol; 2006 Jun; 132(6):363-75. PubMed ID: 16447040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHARACTERIZATION OF THE MUCIN PHENOTYPE CAN PREDICT GASTRIC CANCER RECURRENCE AFTER ENDOSCOPIC MUCOSAL RESECTION.
    Hondo FY; Kishi H; Safatle-Ribeiro AV; Pessorrusso FCS; Ribeiro U; Maluf-Filho F
    Arq Gastroenterol; 2017 Dec; 54(4):308-314. PubMed ID: 28954038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of gastric and intestinal mucin phenotypes of gastric carcinoma.
    Mabuchi N; Niwa Y; Hirooka Y; Ohmiya N; Itoh A; Maeda O; Ando T; Goto H
    Hepatogastroenterology; 2008; 55(88):2277-81. PubMed ID: 19260522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas.
    Kabashima A; Yao T; Maehara Y; Tsuneyoshi M
    Gastric Cancer; 2005; 8(4):220-7. PubMed ID: 16328596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori-negative Differentiated Adenocarcinoma of the Stomach.
    Nagaya T; Tanaka N; Iwaya Y; Jimbo Y; Tatai T; Ito T; Seki A; Suzawa K; Ochi Y; Hara E; Takata M; Otsuki T; Iwaya M; Hosaka N; Arakura N; Tanaka E; Hasebe O
    Intern Med; 2015; 54(22):2857-62. PubMed ID: 26567998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and molecular characterization of early gastric adenocarcinoma in Helicobacter pylori-uninfected patients: emphasis on differentiated gastric adenocarcinoma.
    Akazawa Y; Ueyama H; Hayashi T; Utsunomiya H; Uchida R; Abe D; Oki S; Suzuki N; Ikeda A; Yatagai N; Komori H; Takeda T; Matsumoto K; Ueda K; Matsumoto K; Asaoka D; Hojo M; Saito T; Yao T; Nagahara A
    J Gastroenterol; 2022 Oct; 57(10):725-734. PubMed ID: 35939123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of early gastric cancers arising in
    Sato C; Hirasawa K; Tateishi Y; Ozeki Y; Sawada A; Ikeda R; Fukuchi T; Nishio M; Kobayashi R; Makazu M; Kaneko H; Inayama Y; Maeda S
    World J Gastroenterol; 2020 May; 26(20):2618-2631. PubMed ID: 32523315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach.
    Vernygorodskyi S
    Exp Oncol; 2013 Jun; 35(2):114-7. PubMed ID: 23828387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.